{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T02:48:39Z","timestamp":1666666119749},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DML"],"published-print":{"date-parts":[[2018,8,28]]},"DOI":"10.2174\/1872312812666180119114013","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T12:05:37Z","timestamp":1516363537000},"page":"14-23","source":"Crossref","is-referenced-by-count":2,"title":["Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells"],"prefix":"10.2174","volume":"12","author":[{"given":"Akira","family":"Ogasawara","sequence":"first","affiliation":[{"name":"Department of Regeneration Medicine, Yokohama City University School of Medicine, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Kato","sequence":"additional","affiliation":[{"name":"Translational Research Department, Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Nihonbashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Torimoto","sequence":"additional","affiliation":[{"name":"Discovery Technology Laboratories Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumika","family":"Aohara","sequence":"additional","affiliation":[{"name":"Discovery Technology Laboratories Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikiya","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Discovery Technology Laboratories Sohyaku Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Toda, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Regeneration Medicine, Yokohama City University School of Medicine, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Regeneration Medicine, Yokohama City University School of Medicine, Yokohama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Drug Metabolism Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/159200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T11:22:36Z","timestamp":1535541756000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/159200\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1872312812666180119114013","relation":{},"ISSN":["1872-3128"],"issn-type":[{"value":"1872-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,28]]}}}